Complimentary Webinar—HCV Testing Developments

Healthcare News | 2012-02-12

Webinar: How laboratory diagnostics can help with today’s challenges in the prevention, detection, and treatment of hepatitis C.

A Hepatitis C Virus (HCV) infection is the most prevalent cause of non-A, non-B hepatitis (NANBH), and infection is often associated with the use of intravenous drugs. The disease can also be transmitted through transfusion of infected blood or blood products, and many countries have imposed mandatory screening to significantly reduce the risk of such transmission.


Safe and sensitive diagnostic tools are required to screen potentially infected individuals and to monitor therapy in support of the most effective treatment for patients diagnosed with HCV.

Siemens Healthcare Diagnostics is pleased to host a complimentary webinar to demonstrate the impact of the laboratory on prevention, detection, and treatment of hepatitis C.

The webinar will feature two presentations by Prof. R. Stefan Ross, Essen University Hospital, University of Duisburg-Essen, Germany, and Dr. Caroline Tinguely, Blutspendedienst SKR Bern AG, Bern, Switzerland, and will be concluded by a Q&A session.

Attend this complementary webinar and learn:

- What new drugs are available to support treatment strategies

- How a new anti-HCV test can support automation and improve routine testing

- How a new anti-HCV test can increase safety

- How laboratories can meet today's hepatitis C testing challenges

New Enzygnost® Anti-HCV 4.0 Assay1

- High sensitivity may reduce the need for PCR pooling

- May support optimized therapy in patients infected with HCV

- Streamline processing of all screening assays for improved workflow, especially in high-volume laboratories and blood banks

- Non-carcinogenic assay ensures safety of lab personnel and environment

Contact Center

International (English): +49 69 797 6602
You can call us Monday through Friday
8 am to 5 pm CET

Enzygnost Anti-HCV 4.0 Assay is under development and not available for sale.

Did this information help you?
Thank you for your response
We detected numbers and/or an '@' symbol in your comment. Are you trying to enter a phone number or email address so that we may contact you, please contact us via our email form instead.

Note: to get a direct personal response, please contact us via our email form.

Thank you